Showing results (391-400 of 974) with videos related to
Sort By:
Pageof 98
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2025
Protected Time, Resources, and Expectations for Academic Oncology Clinical Research PhysiciansDavid E Gerber, Nikhil I Khushalani, Ang Gao, et al.Journal of Surgical Oncology|March 28, 2017
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancerMuhammad Shaalan Beg, Xiumei Huang, Molly A Silvers, et al.Cancer Medicine|August 2, 2025
Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical TrialsSukh Makhnoon, Fabian Robles, Jessica L Lee, et al.Medical and Veterinary Entomology|December 30, 2020
Evaluation of large volume yeast interfering RNA lure-and-kill ovitraps for attraction and control of Aedes mosquitoesL K Hapairai, K Mysore, L D James, et al.International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief ReportYuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, et al.Lung Cancer (Amsterdam, Netherlands)|October 18, 2015
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancerDavid E Gerber, David A Boothman, Farjana J Fattah, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung CancerRamaswamy Govindan, Sumithra J Mandrekar, David E Gerber, et al.Journal of Medicinal Chemistry|July 21, 1998
Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolentaD E Bierer, L G Dubenko, P Zhang, et al.Clinical Lung Cancer|January 22, 2021
Clinician Variation in Ordering and Completion of Low-Dose Computed Tomography for Lung Cancer Screening in a Safety-Net Medical SystemDavid E Gerber, Heidi A Hamann, Olivia Dorsey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancerPuneeth Iyengar, Brian D Kavanagh, Zabi Wardak, et al.Pageof 98